Symbiox Investment Peer Comparison
BSE: 539278
₹1.90
As on 04-Sep-2026IST
Market cap
₹6 Cr
Revenue (TTM)
₹1 Cr
P/E Ratio
36.5
P/B Ratio
0.2
Div. Yield
0 %
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
Market cap (₹ Cr) |
6 | 16,257 | 2,950 | 2,152 | 1,561 |
Revenue (₹ Cr) |
1 | 1,735 | 98 | 115 | 44 |
Net Profit (₹ Cr) |
0.16 | 392.39 | 56.60 | 95.46 | 4.63 |
Net Margin (%) |
11.64 | 20.94 | 57.48 | 81.72 | 10.45 |
RoE (%) |
0.51 | 17.12 | 0.35 | 1.06 | 17.49 |
Price to Earnings |
36.47 | 41.87 | 53.27 | 22.54 | 344.36 |
Price-To-Book |
0.19 | 6.59 | 0.19 | 0.25 | 56.82 |
Income Statement (₹ Cr)
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Operating Revenue
|
1.40 | 1,734.56 | 98.44 | 115.39 | 8.33 |
|
Total Income
|
1.40 | 1,873.86 | 98.46 | 116.81 | 9.95 |
|
Total Expenditure
|
1.18 | 1,294.38 | 21.79 | 6.18 | 3.45 |
|
EBITDA
|
0.22 | 440.18 | 76.65 | 109.21 | 4.87 |
|
Depreciation
|
0.00 | 52.95 | 0.02 | 1.36 | 0.56 |
|
EBIT
|
0.22 | 387.22 | 76.63 | 107.85 | 4.32 |
|
Interest
|
0.00 | 6.79 | 0.41 | 0.00 | 0.24 |
|
Other Income
|
0.00 | 139.30 | 0.02 | 1.43 | 1.63 |
|
Exceptional Items
|
0.00 | 0.00 | -0.02 | 0.00 | 0.00 |
|
Profit before Tax
|
0.22 | 519.74 | 76.23 | 109.27 | 5.70 |
|
Provision for Tax
|
0.06 | 127.35 | 19.63 | 13.81 | 1.17 |
|
Profit after Tax
|
0.16 | 392.39 | 56.60 | 95.46 | 4.53 |
Liabilities (₹ Cr)
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Shareholder's Funds
|
31.88 | 2,369.97 | 15,173.05 | 8,673.45 | 27.27 |
|
Minority Interest
|
0.00 | -0.39 | -2.21 | 0.00 | 0.00 |
|
Non-Current Liabilities
|
0.00 | 34.37 | 1,957.69 | 1,325.87 | 1.30 |
|
Current Liabilities
|
0.10 | 1,405.57 | 7.32 | 0.18 | 9.87 |
|
Total Liabilities
|
32.01 | 2,984.84 | 18,946.98 | 10,734.37 | -- |
Assets (₹ Cr)
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Non-Current Assets
|
0.01 | 1,831.46 | 0.02 | 39.60 | 2.31 |
|
Current Assets
|
31.96 | 1,883.01 | 17,184.45 | 9,957.06 | 35.97 |
|
Total Assets
|
32.01 | 2,984.84 | 18,946.98 | 10,734.37 | -- |
|
Total Debt*
|
0.00 | 0.00 | 0.00 | 0.00 | -- |
|
Net Current Assets
|
31.86 | 477.45 | 17,177.13 | 9,956.88 | 26.10 |
|
Contingent Liabilities
|
-- | 1,529.63 | 17.98 | -- | -- |
Cashflow (₹ Cr)
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Cash From Operating Activities
|
3.58 | 563.34 | 61.71 | 94.10 | -- |
|
Cash Flow from Investing Activities
|
-2.84 | -502.32 | -75.37 | -95.00 | -- |
|
Cash from Financing Activities
|
-- | -21.87 | -0.03 | -0.50 | -- |
|
Net Cash Inflow / Outflow
|
0.75 | 39.15 | -13.68 | -1.40 | -- |
Ratios
Profitability Ratios
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
ROCE (%)
|
0.82 | 24.80 | 0.44 | 1.98 | -- |
|
ROE (%)
|
0.51 | 17.12 | 0.35 | 1.06 | 17.50 |
|
ROA (%)
|
0.51 | 20.55 | 0.31 | 0.93 | 14.58 |
|
EBIT Margin (%)
|
15.64 | 22.32 | 77.84 | 93.46 | 51.83 |
|
Net Margin (%)
|
11.64 | 20.94 | 57.48 | 81.72 | 45.53 |
|
Cash Profit Margin (%)
|
0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Growth Ratios
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Revenue Growth (%)
|
-51.89 | 24.34 | -19.75 | -8.11 | -20.61 |
|
EBIT Growth (%)
|
-35.01 | 9.66 | 32.48 | -8.98 | 37.32 |
|
Net Profit Growth (%)
|
-35.57 | 11.04 | 36.43 | 8.89 | -53.01 |
|
EPS Growth (%)
|
-35.57 | 9.40 | 27.81 | 8.89 | -74.68 |
|
Book Value Growth (%)
|
0.61 | 19.07 | 32.35 | -21.53 | -- |
Valuation Ratios
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Price / Earnings
|
36.47 | 41.87 | 53.26 | 22.54 | 344.43 |
|
Price / Book Value
|
0.19 | 6.59 | 0.19 | 0.25 | 56.13 |
|
Dividend Yield (%)
|
0.00 | 0.49 | 0.00 | 0.02 | 0.03 |
|
EV/EBITDA
|
-35.11 | 33.19 | 36.50 | 19.68 | 320.81 |
|
Market Cap (₹ Cr)
|
9.98 | 0.00 | 3,112.75 | 2,652.46 | -- |
Solvency Ratios
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Debt to Equity
|
0.00 | 0.00 | 0.00 | 0.00 | 0.05 |
|
Short term debt to equity ratio
|
-- | -- | 0.00 | -- | -- |
|
Current Ratio
|
319.64 | 1.34 | 2,348.24 | 55,626.02 | 3.64 |
|
Quick Ratio
|
313.30 | 1.34 | 2,348.24 | 55,626.02 | 1.23 |
|
Interest Coverage
|
564.45 | 77.58 | 186.46 | -- | 24.96 |
Operating Efficiency Ratios
| Symbiox Investment | National Securities Depository | Nalwa Sons Invst | Elcid Investments | Naysaa Securities | |
|---|---|---|---|---|---|
|
Debtors to sales (%)
|
20.43 | 9.87 | 4.88 | -- | 52.44 |
|
Asset Turnover
|
0.04 | 0.91 | 0.01 | 0.01 | 0.27 |
|
Receivable days
|
11.33 | 27.39 | 1.52 | 0.00 | -- |
|
Inventory Days
|
91.53 | 0.00 | 99.79 | 0.00 | -- |
|
Payable days
|
30.52 | -- | 11.82 | -- | -- |
|
Cash Conversion Cycle
|
72.34 | -- | 89.49 | -- | -- |